$RIGL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RIGEL PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RIGEL PHARMACEUTICALS INC. Get notifications about new insider transactions in RIGEL PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.84 | 600 | 5,904 | 1,000 | 400 to 1,000 (+150.00 %) |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.82 | 100 | 982 | 400 | 300 to 400 (+33.33 %) |
Aug 10 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Buy | P | 9.80 | 300 | 2,940 | 300 | 0 to 300 |
Jun 27 2007 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | M | 1.80 | 2,222 | 4,000 | 0 | |
Jun 27 2007 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Buy | M | 1.80 | 2,222 | 4,000 | 2,222 | 0 to 2.2 K |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
May 29 2007 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | Sr. VP Medical Deve ... | Buy | P | 9.68 | 2,000 | 19,351 | 2,000 | 0 to 2 K |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 11.73 | 106,911 | 1,254,066 | 106,911 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 11.73 | 80,000 | 938,400 | 80,000 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 11.73 | 103,788 | 1,217,433 | 103,788 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | Sr. VP Medical Deve ... | Option Exercise | A | 11.73 | 80,000 | 938,400 | 80,000 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 11.73 | 20,000 | 234,600 | 20,000 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | Ex. VP Chief Sci. O ... | Option Exercise | A | 11.73 | 80,000 | 938,400 | 80,000 | |
Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 11.73 | 100,000 | 1,173,000 | 100,000 | |
Jan 25 2007 | RIGL | RIGEL PHARMACEUTIC ... | Goodwin Bradford S | Director | Option Exercise | A | 11.36 | 20,000 | 227,200 | 20,000 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 9.56 | 16,249 | 155,340 | 16,249 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 9.56 | 1,111 | 10,621 | 1,111 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | Grossbard Elliott B | Sr. VP Medical Deve ... | Option Exercise | A | 9.56 | 27,778 | 265,558 | 27,778 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 9.56 | 43,889 | 419,579 | 43,889 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 9.56 | 4,039 | 38,613 | 4,039 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 9.56 | 1,112 | 10,631 | 1,112 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 9.56 | 1,112 | 10,631 | 1,112 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 9.56 | 556 | 5,315 | 556 | |
Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP Finance, Acting ... | Option Exercise | A | 9.56 | 1,000 | 9,560 | 1,000 | |
Jun 01 2006 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
Jun 01 2006 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | GROSSBARD ELLIOT B | Sr. VP Medical Deve ... | Option Exercise | A | 7.40 | 60,000 | 444,000 | 60,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 7.40 | 60,000 | 444,000 | 60,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | Ex. VP Chief Sci. O ... | Option Exercise | A | 7.40 | 55,000 | 407,000 | 55,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 7.40 | 65,000 | 481,000 | 65,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 7.40 | 45,000 | 333,000 | 45,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 7.40 | 20,000 | 148,000 | 20,000 | |
Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | A | 7.40 | 45,000 | 333,000 | 45,000 | |
Dec 08 2005 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 8.12 | 1,000 | 8,120 | 9,000 | 8 K to 9 K (+12.50 %) |
Nov 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Buy | J | 0.00 | 697 | 0 | 697 | 0 to 697 |
Nov 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | J | 0.00 | 11,604 | 0 | 0 | 11.6 K to 0 (-100.00 %) |
Nov 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | J | 0.00 | 315,423 | 0 | 0 | 315.4 K to 0 (-100.00 %) |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 24.28 | 20,000 | 485,600 | 20,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 24.56 | 80,000 | 1,964,800 | 80,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 24.56 | 55,000 | 1,350,800 | 55,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 24.56 | 40,000 | 982,400 | 40,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | GROSSBARD ELLIOT B | Sr. VP Medical Deve ... | Option Exercise | A | 24.56 | 65,000 | 1,596,400 | 65,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | A | 24.56 | 90,000 | 2,210,400 | 90,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | Ex. VP Chief Sci. O ... | Option Exercise | A | 24.56 | 93,000 | 2,284,080 | 93,000 | |
Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 24.56 | 200,000 | 4,912,000 | 200,000 | |
Jul 27 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.55 | 1,590 | 32,671 | 11,604 | 13.2 K to 11.6 K (-12.05 %) |
Jul 27 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.55 | 43,210 | 887,879 | 315,423 | 358.6 K to 315.4 K (-12.05 %) |
Jul 27 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.26 | 4,513 | 91,419 | 13,194 | 17.7 K to 13.2 K (-25.49 %) |
Jul 27 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.26 | 122,684 | 2,485,198 | 358,633 | 481.3 K to 358.6 K (-25.49 %) |
Jul 22 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.75 | 21 | 436 | 17,934 | 18 K to 17.9 K (-0.12 %) |
Jul 22 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.75 | 565 | 11,724 | 487,490 | 488.1 K to 487.5 K (-0.12 %) |
Jul 25 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.37 | 227 | 4,623 | 17,707 | 17.9 K to 17.7 K (-1.27 %) |
Jul 25 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.37 | 6,173 | 125,727 | 481,317 | 487.5 K to 481.3 K (-1.27 %) |
Jul 20 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.75 | 3,997 | 82,940 | 17,955 | 22 K to 18 K (-18.21 %) |
Jul 20 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.75 | 108,637 | 2,254,272 | 488,055 | 596.7 K to 488.1 K (-18.21 %) |
Jul 20 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.76 | 1,256 | 26,081 | 21,952 | 23.2 K to 22 K (-5.41 %) |
Jul 20 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 20.76 | 34,153 | 709,184 | 596,692 | 630.8 K to 596.7 K (-5.41 %) |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | M | 9.20 | 15,000 | 138,000 | 16,249 | |
May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Sell | S | 19.71 | 15,000 | 295,650 | 4,385 | 19.4 K to 4.4 K (-77.38 %) |
May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Buy | M | 9.20 | 15,000 | 138,000 | 19,385 | 4.4 K to 19.4 K (+342.08 %) |
Feb 04 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 19.30 | 6,667 | 128,673 | 6,667 | |
Feb 04 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 19.30 | 13,333 | 257,327 | 13,333 | |
Mar 30 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Buy | P | 15.99 | 1,000 | 15,990 | 4,385 | 3.4 K to 4.4 K (+29.54 %) |
Feb 09 2005 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 18.78 | 300 | 5,633 | 8,000 | 7.7 K to 8 K (+3.90 %) |
Feb 09 2005 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 18.78 | 200 | 3,756 | 7,700 | 7.5 K to 7.7 K (+2.67 %) |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 22.17 | 2,500 | 55,425 | 2,500 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 22.17 | 38,751 | 859,110 | 38,751 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | GROSSBARD ELLIOT B | Sr. VP Medical Deve ... | Option Exercise | A | 22.17 | 32,222 | 714,362 | 32,222 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Option Exercise | A | 22.17 | 12,500 | 277,125 | 12,500 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | A | 22.17 | 27,777 | 615,816 | 27,777 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | Ex. VP Chief Sci. O ... | Option Exercise | A | 22.17 | 11,250 | 249,413 | 11,250 | |
Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 22.17 | 15,000 | 332,550 | 15,000 | |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.40 | 15 | 351 | 0 | 15 to 0 (-100.00 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.36 | 200 | 4,672 | 15 | 215 to 15 (-93.02 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.35 | 100 | 2,335 | 215 | 315 to 215 (-31.75 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.34 | 300 | 7,002 | 315 | 615 to 315 (-48.78 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.33 | 700 | 16,331 | 615 | 1.3 K to 615 (-53.23 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.29 | 100 | 2,329 | 1,315 | 1.4 K to 1.3 K (-7.07 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.28 | 100 | 2,328 | 1,415 | 1.5 K to 1.4 K (-6.60 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.27 | 200 | 4,654 | 1,515 | 1.7 K to 1.5 K (-11.66 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.26 | 1,700 | 39,542 | 1,715 | 3.4 K to 1.7 K (-49.78 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.25 | 10,503 | 244,195 | 3,415 | 13.9 K to 3.4 K (-75.46 %) |
Jan 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.28 | 3,335 | 77,639 | 0 | 3.3 K to 0 (-100.00 %) |
Jan 26 2005 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Buy | J | 0.00 | 4,917 | 0 | 10,905 | 6 K to 10.9 K (+82.11 %) |
Jan 26 2005 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | J | 0.00 | 481,396 | 0 | 0 | 481.4 K to 0 (-100.00 %) |
Jan 26 2005 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | J | 0.00 | 459,563 | 0 | 0 | 459.6 K to 0 (-100.00 %) |
Jan 26 2005 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | S | 19.10 | 2,332 | 44,541 | 0 | 2.3 K to 0 (-100.00 %) |
Nov 29 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 23.49 | 868,055 | 20,387,227 | 0 | 868.1 K to 0 (-100.00 %) |
Nov 05 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.11 | 4,473 | 116,773 | 23,207 | 27.7 K to 23.2 K (-16.16 %) |
Nov 05 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.11 | 121,577 | 3,173,901 | 630,846 | 752.4 K to 630.8 K (-16.16 %) |
Nov 29 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 23.49 | 868,055 | 20,387,227 | 0 | 868.1 K to 0 (-100.00 %) |
Oct 22 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.08 | 92 | 2,400 | 27,680 | 27.8 K to 27.7 K (-0.33 %) |
Oct 22 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 25.03 | 6,209 | 155,411 | 27,772 | 34 K to 27.8 K (-18.27 %) |
Oct 22 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.08 | 2,508 | 65,415 | 752,423 | 754.9 K to 752.4 K (-0.33 %) |
Oct 22 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 25.03 | 168,791 | 4,224,839 | 754,931 | 923.7 K to 754.9 K (-18.27 %) |
Oct 19 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.26 | 956 | 25,104 | 33,981 | 34.9 K to 34 K (-2.74 %) |
Oct 19 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.26 | 25,994 | 682,600 | 923,722 | 949.7 K to 923.7 K (-2.74 %) |
Oct 19 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.33 | 688 | 18,112 | 34,937 | 35.6 K to 34.9 K (-1.93 %) |
Oct 19 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 26.33 | 18,712 | 492,614 | 949,716 | 968.4 K to 949.7 K (-1.93 %) |
Oct 06 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Option Exercise | X | 5.76 | 868,055 | 4,999,997 | 0 | |
Oct 06 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Buy | X | 5.76 | 868,055 | 4,999,997 | 868,055 | 0 to 868.1 K |
Oct 06 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Option Exercise | X | 5.76 | 868,055 | 4,999,997 | 0 | |
Oct 06 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Buy | X | 5.76 | 868,055 | 4,999,997 | 868,055 | 0 to 868.1 K |
Sep 20 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 32.33 | 14,956 | 483,486 | 0 | 15 K to 0 (-100.00 %) |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Buy | J | 0.00 | 14,956 | 0 | 14,956 | 0 to 15 K |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | Buy | J | 0.00 | 475,026 | 0 | 475,026 | 0 to 475 K | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | Buy | J | 0.00 | 475,026 | 0 | 475,026 | 0 to 475 K | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Buy | J | 0.00 | 1,766 | 0 | 3,335 | 1.6 K to 3.3 K (+112.56 %) |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Buy | J | 0.00 | 13,918 | 0 | 13,918 | 0 to 13.9 K |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | Buy | J | 0.00 | 475,026 | 0 | 475,026 | 0 to 475 K | |
Sep 15 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | Sell | J | 0.00 | 1,687,072 | 0 | 0 | 1.7 M to 0 (-100.00 %) | |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | M | 1.80 | 5,500 | 9,900 | 7,000 | |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Sell | S | 20.30 | 200 | 4,060 | 3,757 | 4 K to 3.8 K (-5.05 %) |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Sell | S | 20.24 | 100 | 2,024 | 3,957 | 4.1 K to 4 K (-2.46 %) |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Sell | S | 20.23 | 9,400 | 190,162 | 4,057 | 13.5 K to 4.1 K (-69.85 %) |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Sell | S | 20.21 | 200 | 4,042 | 13,457 | 13.7 K to 13.5 K (-1.46 %) |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Sell | S | 20.20 | 100 | 2,020 | 13,657 | 13.8 K to 13.7 K (-0.73 %) |
Sep 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Buy | M | 1.80 | 5,500 | 9,900 | 13,757 | 8.3 K to 13.8 K (+66.61 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 19.77 | 826 | 16,330 | 1,772,099 | 1.8 M to 1.8 M (-0.05 %) |